LOW-DOSE DECITABINE COMBINED WITH MODIFIED BUCY AS CONDITIONING REGIMENT FOLLOW BY ALLOGENEIC STEM CELL TRANSPLANTATION FOR THE TREATMENT OF ADVANCED AML/MDS PATIENTS

被引：0
|
作者：
Shi, X. [1 ]
Ge, L. [1 ]
Sun, A. [1 ]
Zhu, X. [1 ]
Qiu, H. [1 ]
Jin, Z. [1 ]
Miao, M. [1 ]
Fu, C. [1 ]
Ma, X. [1 ]
Chen, F. [1 ]
Xue, S. [1 ]
Han, Y. [1 ]
Xue, M. [1 ]
Tang, X. [1 ]
Wu, D. [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Suzhou, Peoples R China
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P355
引用
收藏
页码：122 / 122
页数：1
相关论文
共 50 条
  • [1] Low-dose decitabine combined with modified BUCY as conditioning regiment follow by allogeneic stem cell transplantation for the treatment of advanced AML/MDS patient
    Tang, X.
    Shi, X.
    Wu, D.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S445 - S446
  • [2] Low-dose decitabine-intensified modified conditioning regimen alleviates aGVHD in AML/MDS patients treated with allogeneic hematopoietic stem cell transplantation
    Zhu, Jinye
    Wang, Qingya
    Ren, Hanyun
    Dong, Yujun
    Yin, Yue
    Wang, Qian
    Liang, Zeyin
    Liu, Wei
    Wang, Qingyun
    Wang, Bingjie
    Li, Yuan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [3] Efficacy of Low-Dose Decitabine in the Early Relapse of AML/MDS after Allogeneic Hematopoietic Stem Cell Transplantation
    Xu Guo-Fa
    Chen Ting
    Liu Huanfeng
    Lin Shijia
    Lei Gao
    Cheng Zhang
    Yao Liu
    Xi Zhang
    Zeng, Defu
    Kong Peiyan
    BLOOD, 2018, 132
  • [4] WHICH CONDITIONING REGIMEN IS MORE EFFECTIVE FOR HIGH-RISK PATIENTS WITH AML/MDS : COMPARING LOW-DOSE DECITABINE COMBINED WITH MODIFIED BUCY WITH MODIFIED BUCY FOLLOWED BY ALLO-HSCT
    Cao, J.
    Shi, X.
    Ge, L.
    Sun, A.
    Zhu, X.
    Qiu, H.
    Jin, Z.
    Miao, M.
    Fu, C.
    Ma, X.
    Chen, F.
    Xue, S.
    Han, Y.
    Xue, M.
    Mao, X.
    Wu, D.
    Tang, X.
    HAEMATOLOGICA, 2016, 101 : 286 - 286
  • [5] Which conditioning regimen is more effective for high-risk patients with acute myeloid leukaemia/myelodysplastic syndrome: comparing Low-dose decitabine combined with modified BUCY with modified BUCY followed by allogeneic stem cell transplantation
    Cao, J.
    Shi, X.
    Ge, L.
    Sun, A.
    Zhu, X.
    Qiu, H.
    Jin, Z.
    Miao, M.
    Fu, C.
    Ma, X.
    Chen, F.
    Xue, S.
    Han, Y.
    Xue, M.
    Mao, X.
    Wu, D.
    Tang, X.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S443 - S443
  • [6] Non-intensive AML/MDS treatment with low-dose decitabine prior to reduced-intensity conditioning (RIC) and allogeneic blood stem cell transplantation of older patients.
    Luebbert, Michael
    Bertz, Hartmut
    Rueter, Bjorn H.
    Mertelsmann, Roland H.
    Finke, Jurgen
    BLOOD, 2006, 108 (11) : 406B - 406B
  • [7] Dose-reduced conditioning followed by allogeneic stem cell transplantation in patients with MDS or secondary AML
    Kröger, N
    Schwerdtfeger, R
    Bornhäuser, M
    Ehninger, G
    Runde, V
    Beyer, J
    Kiehl, M
    Schetelig, J
    Siegert, W
    Schäfer-Eckert, K
    Wandt, H
    Sayer, HG
    Kröger, M
    Zabelina, T
    Zander, AR
    BONE MARROW TRANSPLANTATION, 2002, 29 : S57 - S57
  • [8] Low-dose decitabine as part of a modified Bu-Cy conditioning regimen improves survival in AML patients with active disease undergoing allogeneic hematopoietic stem cell transplantation
    Xiaowen Tang
    Benigno C. Valdez
    Yunju Ma
    Qianqian Zhang
    Changju Qu
    Haiping Dai
    Jia Yin
    Zheng Li
    Ting Xu
    Yang Xu
    Jia Chen
    Xiaming Zhu
    Zixing Chen
    Depei Wu
    Borje S. Andersson
    Bone Marrow Transplantation, 2021, 56 : 1674 - 1682
  • [9] Low-dose decitabine as part of a modified Bu-Cy conditioning regimen improves survival in AML patients with active disease undergoing allogeneic hematopoietic stem cell transplantation
    Tang, Xiaowen
    Valdez, Benigno C.
    Ma, Yunju
    Zhang, Qianqian
    Qu, Changju
    Dai, Haiping
    Yin, Jia
    Li, Zheng
    Xu, Ting
    Xu, Yang
    Chen, Jia
    Zhu, Xiaming
    Chen, Zixing
    Wu, Depei
    Andersson, Borje S.
    BONE MARROW TRANSPLANTATION, 2021, 56 (07) : 1674 - 1682
  • [10] Impact of low-dose TBI on outcomes of reduced intensity conditioning allogeneic hematopoietic stem cell transplantation for AML
    J Aoki
    S Seo
    H Kanamori
    M Tanaka
    T Fukuda
    M Onizuka
    N Kobayashi
    T Kondo
    M Sawa
    N Uchida
    K Iwato
    T Icihnohe
    Y Atsuta
    S Yano
    A Takami
    Bone Marrow Transplantation, 2016, 51 : 604 - 606
12345